Immunitybio (IBRX) had the highest return between October 10, 2023 and November 15, 2023 by a mid-cap US stock, returning 194.2%.
| ASSET | DATE | % RETURN |
|---|---|---|
Immunitybio (IBRX) | 10/10/2023 - 11/15/2023 | 194.24% |
Scholar Rock (SRRK) | 10/10/2023 - 11/15/2023 | 65% |
TG Therapeutics (TGTX) | 10/10/2023 - 11/15/2023 | 57.4% |
Spirit Aerosystems (SPR) | 10/10/2023 - 11/15/2023 | 47.76% |
Impinj (PI) | 10/10/2023 - 11/15/2023 | 43.99% |
HCI (HCI) | 10/10/2023 - 11/15/2023 | 42.55% |
Triumph (TGI) | 10/10/2023 - 11/15/2023 | 41.06% |
F&G Annuities & Life (FG) | 10/10/2023 - 11/15/2023 | 40.42% |
Inter & Co Inc Class A Common Shares (INTR) | 10/10/2023 - 11/15/2023 | 39.5% |
Customers Bancorp (CUBI) | 10/10/2023 - 11/15/2023 | 38.92% |
Lemonade (LMND) | 10/10/2023 - 11/15/2023 | 38.7% |
Arcellx (ACLX) | 10/10/2023 - 11/15/2023 | 38.51% |
American Superconductor (AMSC) | 10/10/2023 - 11/15/2023 | 38.35% |
Chefs Warehouse (CHEF) | 10/10/2023 - 11/15/2023 | 38.19% |
NCR Atleos (NATL) | 10/10/2023 - 11/15/2023 | 37.78% |
Oscar Health (OSCR) | 10/10/2023 - 11/15/2023 | 37.31% |
Frontier Communications Parent (FYBR) | 10/10/2023 - 11/15/2023 | 36.48% |
StoneCo (STNE) | 10/10/2023 - 11/15/2023 | 36.01% |
Rhythm Pharmaceuticals (RYTM) | 10/10/2023 - 11/15/2023 | 35.77% |
TransMedics (TMDX) | 10/10/2023 - 11/15/2023 | 35.63% |
Ultrapar Participacoes SA ADR (UGP) | 10/10/2023 - 11/15/2023 | 34.78% |
Celcuity LLC (CELC) | 10/10/2023 - 11/15/2023 | 34.7% |
BW LPG (BWLP) | 10/10/2023 - 11/15/2023 | 34.5% |
Gap (GAP) | 10/10/2023 - 11/15/2023 | 34.38% |
AES (AES) | 10/10/2023 - 11/15/2023 | 33.76% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
